Literature DB >> 29123818

Prolonged hypotension induced by ingesting a topical minoxidil solution: analysis of minoxidil and its metabolites.

Satoshi Kikuchi1, Yuji Fujita1,2, Makoto Onodera1, Yasuhisa Fujino1, Yoshihiro Inoue1.   

Abstract

Case: A 47-year-old man ingested 60 mL of a topical solution (3,000 mg minoxidil) and presented with prolonged hypotension. Treatment with dopamine hydrochloride and noradrenaline provided blood pressure control. Serum unchanged minoxidil concentrations at 4 and 16 h after ingestion were 4,994 and 33.9 ng/mL, respectively. Urine concentrations of unchanged minoxidil, minoxidil-O-glucuronide, and minoxidil-N-O-sulfate at 16 h after ingestion were 360.4, 1,953, and 104.5 ng/mL, respectively. Outcome: The serum unchanged minoxidil concentration rapidly decreased over a short interval. However, the patient needed to receive vasopressor support for the first 4 days after being admitted to the hospital. The urine minoxidil-O-glucuronide concentration was higher than the concentrations of unchanged minoxidil and minoxidil-N-O-sulfate.
Conclusion: Although the serum concentration of unchanged minoxidil rapidly decreased, ingesting large amounts of a topical minoxidil solution can have serious and prolonged cardiovascular effects. Analyzing the minoxidil-O-glucuronide concentration in urine is useful for diagnosing minoxidil poisoning.

Entities:  

Keywords:  Antihypertensive agents; blood pressure; minoxidil glucuronide; minoxidil sulfate

Year:  2016        PMID: 29123818      PMCID: PMC5667325          DOI: 10.1002/ams2.196

Source DB:  PubMed          Journal:  Acute Med Surg        ISSN: 2052-8817


  7 in total

1.  Pharmacokinetics of minoxidil in patients with cirrhosis and healthy volunteers.

Authors:  M H Adams; W J Poynor; W R Garnett; H T Karnes; J J Ferry; K K Ryan; M A Sarkar
Journal:  Biopharm Drug Dispos       Date:  1998-11       Impact factor: 1.627

2.  The pharmacokinetics of 2.5- to 10-mg oral doses of minoxidil in healthy volunteers.

Authors:  J C Fleishaker; N A Andreadis; I R Welshman; C E Wright
Journal:  J Clin Pharmacol       Date:  1989-02       Impact factor: 3.126

3.  Minoxidil analysis in human plasma using high-performance liquid chromatography with electrochemical detection. Application to pharmacokinetic studies.

Authors:  G Carrum; D R Abernethy; M Sadhukhan; C E Wright
Journal:  J Chromatogr       Date:  1986-08-22

4.  Accidental overdosage of minoxidil in a child.

Authors:  C Isles; A Mackay; P J Barton; I Mitchell
Journal:  Lancet       Date:  1981-01-10       Impact factor: 79.321

5.  Rapid drug extraction from human whole blood using a modified QuEChERS extraction method.

Authors:  Kiyotaka Usui; Yoshie Hayashizaki; Masaki Hashiyada; Masato Funayama
Journal:  Leg Med (Tokyo)       Date:  2012-06-07       Impact factor: 1.376

Review 6.  Minoxidil overdose with ECG changes: case report and review.

Authors:  S W Poff; S R Rose
Journal:  J Emerg Med       Date:  1992 Jan-Feb       Impact factor: 1.484

7.  Pyrimidine and triazine 3-oxide sulfates: a new family of vasodilators.

Authors:  J M McCall; J W Aiken; C G Chidester; D W DuCharme; M G Wendling
Journal:  J Med Chem       Date:  1983-12       Impact factor: 7.446

  7 in total
  1 in total

1.  Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers.

Authors:  Daniela Fukushiro-Lopes; Alexandra D Hegel; Angela Russo; Vitalyi Senyuk; Margaret Liotta; Gyda C Beeson; Craig C Beeson; Joanna Burdette; Ronald K Potkul; Saverio Gentile
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.